EMEA-002342-PIP02-18

Table of contents

Key facts

Invented name
Verzenios
Active substance
abemaciclib
Therapeutic area
Oncology
Decision number
P/0021/2020
PIP number
EMEA-002342-PIP02-18
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral solid dosage form
Condition(s) / indication(s)
  • Treatment of high-grade glioma
  • Treatment of neuroblastoma
Route(s) of administration
  • Oral use
  • Gastric use
Contact for public enquiries
Eli Lilly and Company Limited (US)

Tel.: +1 31 75448941
E-mail: wagle_asvari@lilly.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating